U.S. Markets closed

Amgen Inc. (AMGN)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
171.39+1.35 (+0.79%)
At close: 4:00PM EDT

172.00 +0.61 (0.36%)
After hours: 6:51PM EDT

People also watch
Full screen
Previous Close170.04
Bid170.00 x 100
Ask184.05 x 100
Day's Range170.14 - 172.63
52 Week Range133.64 - 184.21
Avg. Volume3,162,356
Market Cap125.06B
PE Ratio (TTM)16.28
Earnings DateN/A
Dividend & Yield4.60 (2.71%)
Ex-Dividend Date2017-08-15
1y Target EstN/A
Trade prices are not sourced from all markets
  • Market Realist12 hours ago

    What We May See from Amgen’s Vectibix in 2017

    In 2Q17, Amgen’s (AMGN) Vectibix generated revenues of ~$168 million, which represented a ~5% YoY (year-over-year) rise and a ~14% QoQ (quarter-over-quarter) rise. In the US, Vectibix generated revenues ...

  • Barrons.com13 hours ago

    Biogen: Goldman Has Conviction!

    Biogen (BIIB) has had a good, though not great year. Is it time to add it to your portfolio? Shares of Biogen have gained 11.5% so far this year, and while that's better than the S&P 500's 10.3% rise during ...

  • Market Realist14 hours ago

    How Amgen’s Neutropenia Drugs Are Positioned after 2Q17

    In 2Q17, Amgen’s (AMGN) Neulasta generated revenues of ~$1.1 billion, which represented a ~5% YoY (year-over-year) fall and ~10% QoQ (quarter-over-quarter) fall. In the US, Neulasta generated revenues ...